title: Hepatic tumor ablation: application in a community hospital setting.
abstract: Primary liver tumors are a common clinical problem in the United States and worldwide. Resection has historically been used to treat liver lesions. Commonly used liver-directed therapies include transarterial chemoembolization, selective internal radiation therapy, and ablative therapy. Only ablative therapy can cause direct destruction of the targeted tissue. The commercially available modalities in the United States are all based on thermoablative technology. This article examines the various ablative technologies and their application, as well as how these procedures can be performed safely and with optimal outcomes, in a community cancer center.
authors.affiliation: Hepato-Pancreato-Biliary Surgery, Department of General Surgery, Carolinas Medical Center, 1025 Morehead Medical Plaza Drive, Suite 300, Charlotte, NC 28204, USA.
authors.forename: Kwan N
authors.initials: KN
authors.lastname: Lau
authors.forename: Ryan Z
authors.initials: RZ
authors.lastname: Swan
authors.forename: David
authors.initials: D
authors.lastname: Sindram
authors.forename: John B
authors.initials: JB
authors.lastname: Martinie
authors.forename: David A
authors.initials: DA
authors.lastname: Iannitti
mesh_terms: D002173:Cancer Care Facilities; D018278:Carcinoma, Neuroendocrine / Q000473:pathology / Q000628:therapy*; D017115:Catheter Ablation; D015179:Colorectal Neoplasms / Q000473:pathology / Q000628:therapy*; D003131:Combined Modality Therapy; D004621:Embolization, Therapeutic; D006764:Hospitals, Community; D006801:Humans; D008113:Liver Neoplasms / Q000556:secondary / Q000628:therapy*; D014481:United States